Differentiation and function of Th17 T cells.
By Brigitta Stockinger, M. Veldhoen. Current Opinion in Immunology, 2007
812 citations recorded by the source corpus.
Subfields: Immunology
View Paper: https://www.semanticscholar.org/paper/f78cf740660c746008e208c803f4180e2379c9d4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis (2010, background): “In addition to previously recognized T helper 1 (Th1) and Th2 fates, naive CD4 T cells can also differentiate into Th17 and regulatory T (Treg) cells; the balance of Th17 and Treg cells is now considered to be critical for host immunity and the preservation of tolerance (Bettelli et al., 2008; Stock”
- The blood-brain barrier in health and chronic neurodegenerative disorders. (2008, positive): “It is believed that Th17 lymphocytes, which secrete interleukin-17, may play an important role in neuronal killing (Stockinger and Veldhoen, 2007).”
- Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. (2008, background): “the soluble factors IL-6, IL-21, IL-23, and TGF-b and activates STAT3 to induce RORgt expression (Chen and O’Shea, 2008; Stockinger and Veldhoen, 2007; Weaveret al., 2007).”
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt (2008, background): “1610" language="eng" relation="no"> T H -17 cells, T helper cells that produce interleukin 17 (IL-17) and other proinflammatory cytokines, have been shown to have key functions in several mouse autoimmune disease models and are thought to be similarly involved in human diseas”
- Late Developmental Plasticity in the T Helper 17 Lineage (2009, positive): “T helper 17 is a third major CD4+ T cell effector subset important in host protection and autoinflammatory disorders (McGeachy and Cua, 2008; Stockinger and Veldhoen, 2007; Weaver et al., 2007).”
- Specific microbiota direct the differentiation of Th17 cells in the mucosa of the small intestine (2008, positive): “There has been extensive investigation of the cytokine requirements and genetic regulation in Th17 cell differentiation both under well-defined conditions in vitro and in the context of inflammatory stimuli in vivo (Bettelli et al., 2007; Ivanov et al., 2007; Stockinger and Veldhoen, 2007).”
- The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities (2012, background): “In particular, CD4 + T cells become polarized during activation into Th1, Th2, Th17, Treg, or other T helper subtypes (180, 213, 242).”
- Inflammatory signals in dendritic cell activation and the induction of adaptive immunity (2009, background): “Reis e Sousa, unpublished data) and IL-23 (46), which are, respectively, required to drive the differentiation and promote the survival of that type of effector T cell (84, 85).”
- IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance (2007, background): “IL-23, although not involved in Th17 differentiation, plays an important role in maintaining Th17 effector function [3, 4 ]. Th17 cells are responsible for various organ-related autoimmune diseases [5, 6], and both IL-23 and the Th17 pathway correlate with disease severity and immunopathology in di”
- Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis (2010, positive): “IL-23 stimulates survival and proliferation of Th17 cells, a key cell that regulates the production of other inflammatory cytokines (IL-17, IL-22, IL-21, IL-6, tumor necrosis factor (TNF)-α) and is overproduced in dendritic cells and keratinocytes found psoriatic plaques.(8,9) Th1 cells develop from”